US FDA approves therapy for rare immunodeficiency disease | Republic World
Advertisement

Published 16:22 IST, April 29th 2024

US FDA approves X4 Pharmaceuticals' therapy for rare immunodeficiency disease

The announcement led to a significant surge in X4 Pharmaceuticals' shares, which rose by 16% before the market opened on Monday.

Reported by: Business Desk
Follow: Google News Icon
  • share
US FDA
US FDA | Image: Reuters
  • Listen to this article
  • 2 min read

16:22 IST, April 29th 2024

Advertisement